| Enzastaurin studied in …STUDIED_INderived48 of 48show fewer |
|---|
| → studied in | NCT03263026Phase 3 · completed Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ · 48 trials list this drug (0 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03776071Phase 3 · completed A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 · 48 trials list this drug (0 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00308750Phase 2 · completed First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) · 48 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00452413Phase 1/Phase 2 · completed A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer · 48 trials list this drug (0 active) | — | — | Malignant Solid Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00533429Phase 2 · completed Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy · 48 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00420381Phase 2 · completed Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer · 48 trials list this drug (0 active) | — | — | Neoplasm,Carcinoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00428714Phase 2 · completed Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy · 48 trials list this drug (0 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00466440Phase 2 · completed A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients · 48 trials list this drug (0 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00415363Phase 2 · completed Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy · 48 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538681Phase 2 · terminated Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo · 48 trials list this drug (0 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00391118Phase 2 · completed Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") · 48 trials list this drug (0 active) | — | — | Peritoneal Neoplasm,Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00542919Phase 2 · completed A Study for Patients With Non-Hodgkin's Lymphomas · 48 trials list this drug (0 active) | — | — | B-Cell Malignant Neoplasm,T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00744991Phase 2 · completed A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma · 48 trials list this drug (0 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01432951Phase 1 · completed A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma · 48 trials list this drug (0 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536939Phase 2 · terminated Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer · 48 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00586508Phase 2 · completed Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas · 48 trials list this drug (0 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00414960Phase 2 · completed A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers · 48 trials list this drug (0 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00718419Phase 2 · completed A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma · 48 trials list this drug (0 active) | — | — | Multiple Myeloma,Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00267020Phase 2 · completed Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer · 48 trials list this drug (0 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042666Phase 2 · completed A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. · 48 trials list this drug (0 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00437294Phase 2 · terminated Enzastaurin in Combination of Capecitabine to Treat Breast Cancer · 48 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00192114Phase 2 · completed Enzastaurin for Patients With Metastatic Colorectal Cancer · 48 trials list this drug (0 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00402116Phase 1/Phase 2 · completed Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients · 48 trials list this drug (0 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436280Phase 2 · completed Chemotherapy for Participants With Lymphoma · 48 trials list this drug (0 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052273Phase 1 · completed LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors · 48 trials list this drug (0 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00437268Phase 2 · completed A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer · 48 trials list this drug (0 active) | — | — | Colorectal Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00451178Phase 2 · completed A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only · 48 trials list this drug (0 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00612586Phase 2 · completed Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer · 48 trials list this drug (0 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00088205Phase 2 · completed Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma · 48 trials list this drug (0 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00530621Phase 2 · completed Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer · 48 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01388335Phase 1 · completed A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin · 48 trials list this drug (0 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309140Phase 2 · completed An Open Label Study of Oral Enzastaurin in Participants With Cancer · 48 trials list this drug (0 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00451555Phase 2 · completed Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer · 48 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00709995Phase 2 · completed A Study for Participants With Metastatic Renal Cell Carcinoma · 48 trials list this drug (0 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295815Phase 3 · completed Enzastaurin Versus Lomustine in Glioblastoma · 48 trials list this drug (0 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407758Phase 2 · completed Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer · 48 trials list this drug (0 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00475644Phase 2 · completed A Study of Enzastaurin in Participants With Follicular Lymphoma · 48 trials list this drug (0 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00332202Phase 3 · completed PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin · 48 trials list this drug (0 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00469976Phase 2 · withdrawn Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer · 48 trials list this drug (0 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00516607Phase 1 · unknown Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas · 48 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445119Phase 1 · completed A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas · 48 trials list this drug (0 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00685633Phase 2 · withdrawn Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer · 48 trials list this drug (0 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550927Phase 1 · completed Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer · 48 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503724Phase 1 · completed Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors · 48 trials list this drug (0 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00452257Phase 1 · completed A Study of Enzastaurin in Patients With Leukemia · 48 trials list this drug (0 active) | — | — | Lymphoid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00386087Phase 2 · completed Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy · 48 trials list this drug (0 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105092Phase 2 · completed Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. · 48 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00190723Phase 2 · completed A Study of LY317615 in Patients With Brain Tumors · 48 trials list this drug (0 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |